Literature DB >> 14968262

MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience.

Mathias Goyen1, Susanne C Goehde, Christoph U Herborn, Peter Hunold, Florian M Vogt, Elke R Gizewski, Thomas C Lauenstein, Waleed Ajaj, Michael Forsting, Jörg F Debatin, Stefan G Ruehm.   

Abstract

Recent improvements in hardware and software, lack of side effects, as well as diagnostic accuracy make magnetic resonance imaging a natural candidate for preventative imaging. Thus, the purpose of the study was to evaluate the feasibility of a comprehensive 60-min MR-based screening examination in healthy volunteers and a limited number of patients with known target disease. In ten healthy volunteers (7 men, 3 women; mean age, 32.4 years) and five patients (4 men, 1 woman; mean age, 56.2 years) with proven target disease we evaluated the performance of a comprehensive MR screening strategy by combining well-established organ-based MR examination components encompassing the brain, the arterial system, the heart, the lungs, and the colon. All ten volunteers and five patients tolerated the comprehensive MR examination well. The mean in-room time was 63 min. In one volunteer, insufficient colonic cleansing on the part of the volunteer diminished the diagnostic reliability of MR colonography. All remaining components of the comprehensive MR examination were considered diagnostic in all volunteers and patients. In the five patients, the examination revealed the known pathologies [aneurysm of the anterior communicating artery ( n=1), renal artery stenosis ( n=1), myocardial infarct ( n=1), and colonic polyp ( n=2)]. The outlined MR screening strategy encompassing the brain, the arterial system, the heart, the lung, and the colon is feasible. Further studies have to show that MR-based screening programs are cost-effective in terms of the life-years saved.

Entities:  

Mesh:

Year:  2004        PMID: 14968262     DOI: 10.1007/s00330-004-2249-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  [Whole-body MRA on a rolling table platform (AngioSURF)].

Authors:  S G Ruehm; M Goyen; H H Quick; M Schlepütz; H Schlepütz; S Bosk; J Barkhausen; M E Ladd; J F Debatin
Journal:  Rofo       Date:  2000-08

2.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

3.  Incidence of pulmonary tuberculosis by occupation of hospital employees in the National Health Service in England and Wales 1980-84.

Authors:  J A Lunn; V Mayho
Journal:  J Soc Occup Med       Date:  1989

4.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

5.  Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits.

Authors:  Jörg Barkhausen; Wolfgang Ebert; Jörg F Debatin; Hanns-Joachim Weinmann
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

6.  Dark lumen MR-colonography: initial experience.

Authors:  T C Lauenstein; C U Herborn; F M Vogt; S C Göhde; J F Debatin; S G Ruehm
Journal:  Rofo       Date:  2001-09

7.  Gradient echo magnetic resonance imaging in the prediction of hemorrhagic vs ischemic stroke: a need for the consideration of the extent of leukoariosis.

Authors:  Dong-Eog Kim; Hee-Joon Bae; Seung-Hoon Lee; Ho Kim; Byung-Woo Yoon; Jae-Kyu Roh
Journal:  Arch Neurol       Date:  2002-03

8.  Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography.

Authors:  Mathias Goyen; Christoph U Herborn; Thomas C Lauenstein; Jörg Barkhausen; Patrick Veit; Silke Bosk; Jörg Debatin; Stefan G Ruehm
Journal:  Invest Radiol       Date:  2002-05       Impact factor: 6.016

9.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

Review 10.  New concepts in lung cancer screening.

Authors:  Jonathan R C Ellis; Fergus V Gleeson
Journal:  Curr Opin Pulm Med       Date:  2002-07       Impact factor: 3.155

View more
  9 in total

Review 1.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

Review 2.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

3.  Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Stefan G Ruehm; Jörg F Debatin
Journal:  Eur Radiol       Date:  2005-09-21       Impact factor: 5.315

4.  [Whole-body MRI and PET/CT in tumor diagnosis].

Authors:  G P Schmidt; R Schmid; K Hahn; M F Reiser
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

Review 5.  Metastatic disease of the spine.

Authors:  Cosma Andreula; Mario Murrone
Journal:  Eur Radiol       Date:  2005-02-05       Impact factor: 5.315

Review 6.  [Screening in cardiovascular diseases].

Authors:  H Kramer; S Weckbach; G van Kaick; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

Review 7.  Whole-body magnetic resonance angiography at 3.0 Tesla.

Authors:  Michael Fenchel; Kambiz Nael; Achim Seeger; Ulrich Kramer; Roya Saleh; Stephan Miller
Journal:  Eur Radiol       Date:  2008-02-15       Impact factor: 7.034

8.  Whole-body MRI for preventive health screening: A systematic review of the literature.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  J Magn Reson Imaging       Date:  2019-04-01       Impact factor: 4.813

Review 9.  Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies.

Authors:  Frank M Zijta; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2009-11-21       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.